FDA. US: The U.S. Food and Drug Administration today allowed marketing of the
Eclipse System for the treatment of fecal incontinence (FI) in adult
women. Fecal incontinence is the inability to control bowel movements and is
a common problem, especially among older adults. The most common cause
of FI is damage to the muscles around the anus (anal sphincters).
Vaginal childbirth can damage the anal sphincters or their nerves, which
is why FI impacts women about twice as often as men.